5th LifeSciences BC Investor Summit Attracts International Interest – Financial Post

0
48

Article content

VANCOUVER, British Columbia — LifeSciences BC, a non-profit, industry association which supports the life sciences sector of British Columbia, and Lumira Ventures, a leading North American healthcare venture capital firm, will host the 5th Annual LifeSciences BC’s Investor Summit in Vancouver, B.C., virtually on November 2nd and 3rd, 2020.

With keynotes given by Mr. Daniel Hétu, Managing Director of Lumira Ventures and Mr. Peter Greenleaf, CEO of Aurinia Pharmaceuticals, the event brings together prominent industry stakeholders from the healthcare innovation ecosystem for company pitching and fostering of strategic partnerships with international investors. At this year’s Annual Investor Summit, companies from across the life sciences sector are pitching from the following areas: Digital Health, Medical Devices, Medical Technology, Diagnostics, and Biotechnology. International investors are attending from Japan, France, China, Hong Kong and the United States.

This premier event will profile more than 30 digital health, therapeutics, and medical technology entrepreneurs from British Columbia’s highly acclaimed life sciences sector. Each of the selected companies will have the opportunity to present their company’s story and receive feedback and engagement from a wide range of investor stakeholders including, angel investors, venture capitalists, corporate ventures and funding foundations. The event also includes ‘Reverse Pitches’from global pharma companies including Amgen, Johnson & Johnson and Takeda about the innovations they are interested in, plus, presentations from the Trade Commissioner Service of Global Affairs Canadaabout the unique opportunities that exists for British Columbia’s life sciences companies globally.

LEAVE A REPLY

Please enter your comment!
Please enter your name here